Levels of Trimethylamine N-Oxide and Lipopolysaccharides in Vascular and ıdiopathic erectile dysfunction

Area of Science:

• Microbiology
• Cardiovascular Health
• Urology

Background:

• Gut microbiota metabolites influence endothelial function and cardiovascular health.
• Metabolites such as lipopolysaccharides (LPS) and trimethylamine-N-oxide (TMAO) are implicated in atherosclerosis and hypertension.
• Erectile dysfunction (ED) can be linked to underlying vascular and endothelial health.

Purpose of the Study:

• To investigate the association between gut microbiota metabolites (LPS and TMAO) and erectile dysfunction (ED).
• To compare LPS and TMAO levels in patients with vascular ED, idiopathic ED, and healthy controls.
• To explore the role of gut microbiota-derived metabolites in the pathophysiology of ED.

Main Methods:

• A study involving 151 participants: 50 vascular ED, 50 idiopathic ED, and 51 healthy controls.
• Clinical assessment including the International Index of Erectile Function (IIEF), laboratory tests, and imaging.
• Measurement of serum levels of trimethylamine-N-oxide (TMAO) and lipopolysaccharides (LPS).

Main Results:

• No significant differences in age or TMAO levels were observed between the groups.
• Lipopolysaccharides (LPS) levels were significantly higher in the vascular ED group compared to idiopathic ED and control groups (p<0.05).
• Elevated LPS suggests a role in endothelial dysfunction associated with vascular ED.

Conclusions:

• Gut microbiota metabolites, particularly LPS, play a significant role in the pathophysiology of ED via endothelial dysfunction.
• Modulating the gut microbiota could be a potential strategy for preventing ED.
• Targeting gut microbiota may offer novel therapeutic approaches for managing existing ED.